Sodium Bicarbonate in Preventing Contrast Induced Nephropathy (SIPCIN)
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 17, 2007 | ||||
| Last Updated Date | July 24, 2010 | ||||
| Start Date ICMJE | June 2007 | ||||
| Primary Completion Date | May 2010 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Incidence of Contrast Induced nephropathy [ Time Frame: 48 hours ] [ Designated as safety issue: Yes ] | ||||
| Original Primary Outcome Measures ICMJE |
Incidence of Contrast Induced nephropathy [ Time Frame: 48 hours ] | ||||
| Change History | Complete list of historical versions of study NCT00531765 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE |
Incidence of in-hospital morbidity (such as need for hemo-dialysis, development of volume overload) and mortality as well as efficacy and safety of the two strategies in relation to the presence of CIN risk factors. [ Time Frame: one week ] | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Sodium Bicarbonate in Preventing Contrast Induced Nephropathy | ||||
| Official Title ICMJE | Sodium Bicarbonate in Preventing Contrast Induced Nephropathy (SIPCIN): A Randomized Controlled Study | ||||
| Brief Summary | We plan to conduct an open-label, randomized, stratified, parallel-group study to compare normal saline infusion to sodium bicarbonate infusion. |
||||
| Detailed Description | We plan to conduct an open-label, randomized, stratified, parallel-group study to compare normal saline infusion to sodium bicarbonate infusion. 220 adult patients scheduled for routine cardiac catheterization will be enrolled. They will stratified according to the presence or absence of DM, or an estimated GER of less than 60 ml/hr before being block-randomized to the two groups. The incidence of CIN will be determined based on the average of two measurements of creatinine level before and 48 hours after the procedure, and an increase of 25% or 0.5 mg/dL (44.2 umol/L) or more. |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
||||
| Condition ICMJE | Contrast Induced Nephropathy | ||||
| Intervention ICMJE | Other: sodium bicarbonate infusion
short infusion of sodium bicarbonate |
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Estimated Enrollment ICMJE | 220 | ||||
| Completion Date | May 2010 | ||||
| Primary Completion Date | May 2010 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria: All adult patients (18 years and above) who are scheduled for cardiac catechization and have abnormal but stable renal function will be eligible for enrollment. Abnormal renal function is defined as a creatinine level exceeding the normal range (more than 115 or 96 um/L in males and females, respectively, in KFSH&RC laboratories) or eGFR less than 60 ml/min Exclusion Criteria: Patients who fall under any of the following categories will be excluded:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Saudi Arabia | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00531765 | ||||
| Other Study ID Numbers ICMJE | RAC 2071003 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Fawaz Alturki, King Faisal Specialist Hospital & Research center | ||||
| Study Sponsor ICMJE | King Faisal Specialist Hospital & Research Center | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | King Faisal Specialist Hospital & Research Center | ||||
| Verification Date | July 2010 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||